Press Releases from IRG, LLC (3 total)
Trials Show Promise of Human Virus to Treat Head and Neck Cancer Patients
Leeds, UK - April 3, 2012 -- A naturally-occurring harmless human virus may be able to boost the effects of two standard chemotherapy drugs in some cancer patients, according to early stage trial data published today in Clinical Cancer Research.
RT3D, trade name Reolysin, is a new drug developed by Oncolytics Biotech Inc with preclinical and clinical studies conducted at The Institute of Cancer Research (ICR) and The Royal Marsden Hospital.…
BrainStorm Cell Therapeutics Expands Pipeline with the Initiation of a Study for …
Proposed Trial Will Build on NurOwn(TM) Platform to Meet Unmet Needs of Patients with Neurodegenerative Disorders.
NEW YORK & PETACH TIKVAH, ISRAEL, Mar 13, 2012 -- BrainStorm Cell Therapeutics Inc., a developer of adult stem cell technologies and CNS therapeutics, announces plans to initiate a preclinical study assessing the efficacy of its NurOwn(TM) stem cell technology in patients with Multiple Sclerosis (MS). Positive proof-of-concept results for MS have been confirmed in…
NBA Fans Sure That Jeremy Lin Is For Real; In China, Thousands of His Jerseys Ar …
Stony Brook, NY (February 25, 2012) -- It took only 10 days for New York Knicks point guard Jeremy Lin to move from unknown Harvard grad to international, cover-of-Sports Illustrated sensation. That sent New York Times reporters scurrying downtown to discover whether the sharp-eyed basketball phenom had been paid the highest compliment: whether products associated with him, like jerseys and shoes, had been counterfeited and were being sold on the…
